In summary, FOXM1 inhibits the NF-κB signaling pathway through the transcriptional activation of SIRT4, which inhibits the NLRP3 inflammasome and prevents kidney injury and podocyte death in diabetic nephropathy patients. This evidence concerns the gene FOXM1 and diabetic kidney disease.